Skip to main content

Experimental Investigation of Hypolipidemic and Anti-Atherosclerotic Drugs with Different Mechanism of Action

  • Chapter
Atherosclerosis

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 82))

  • 26 Accesses

Abstract

In the Soviet Union the following drugs are used to reduce the plasma level of cholesterol and triglycerides in patients with hyperlipidemias: miscleron (Clofibrate), nicotinic acid, β-sitosterol and the preparations containing unsaturated fatty acids. Amongst them there are arachiden and conlitol. Arachiden is a mixture of ethyl esters of arachidonic, linoleic, linolenic, pentaene and hexaene acids. It is prepared from the lipid fraction of cattle pancreas. Conlitol is a mixture of ethyl esters of unsaturated fatty acids isolated from linseed oil. Both preparations are used orally.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Day, C.E., Powell, J.R., Levy, R.S.: Sulfated polysaccharide inhibition of aortic uptake of low density lipoproteins. Artery 1:126–137, 1975.

    CAS  Google Scholar 

  2. Klimov, A.N., Poliakova, E.D., Remizov, A.L., Petrova, L.A.: The study of the effect of some possible antimetabolites of mevalonic acid on the biosynthesis of cholesterol in rat liver. Biochimia 32:88–92, 1967. In Russian.

    CAS  Google Scholar 

  3. Morrison, L.M.: Reduction of ischemic coronary heart disease by chondroitin sulfate A. Angiology 22:165–174, 1971.

    Article  PubMed  CAS  Google Scholar 

  4. Morrison, L.M., Bajwa, G.S., Alein-Slater, R.B., Ershoff, B.H.: Prevention of vascular lesions by chondroitin sulfate A in the coronary artery and aorta of rats induced by a hyper-vitaminosis D, cholesterol-containing diet. Atherosclerosis 16:105–118, 1972.

    Article  PubMed  CAS  Google Scholar 

  5. Shimamoto, T., Numano, F., Fujita, T.: Atherosclerosis-inhibiting effect of an antibradykinin agent, pyridinolcarbamate. Am. Heart J. 71:216–227, 1966.

    Article  PubMed  CAS  Google Scholar 

  6. Shimamoto, T.: New concept on atherogenesis and treatment of atherosclerotic diseases with endothelial cell relaxant. Jap. Heart J. 13:537–562, 1972.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1977 Plenum Press, New York

About this chapter

Cite this chapter

Klimov, A.N., Ryzhenkov, V.E., Petrova, L.A., Polyakova, E.D. (1977). Experimental Investigation of Hypolipidemic and Anti-Atherosclerotic Drugs with Different Mechanism of Action. In: Manning, G.W., Haust, M.D. (eds) Atherosclerosis. Advances in Experimental Medicine and Biology, vol 82. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-4220-5_108

Download citation

  • DOI: https://doi.org/10.1007/978-1-4613-4220-5_108

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-4222-9

  • Online ISBN: 978-1-4613-4220-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics